Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0686 in Osteoarthritis of the Knee or Hip
NCT00296569Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0686 in osteoarthritis (OA), sponsored by Merck & Co.. Started Sep 2005; status: completed.
02
Drugs
MK-0686
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00296569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296569.